Drawing for KAIKO

USPTO serial 79434666

KAIKO

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
Examiner
LOZEAU, BRANDON THOMAS
Law office
TMO LAW OFFICE 127

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KAIKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of metabolic diseases, diabetes, hypertension, hypercholesterolemia, and hyperlipidemia; antiallergic agents, namely, antiallergic medicines; anti-histamines; vitamin preparations; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical or veterinary purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; nutritional food additives in the nature of natural food extracts derived from silkworms for medical purposes, medicinal tonics and substitutes therefor; royal jelly for medical purposes; chondroitin preparations; food enriching preparations being nutritional supplements; protein-based medical preparations and amino acid preparations for medical or veterinary purposes; saccharide preparations for medical purposes; mineral preparations for medical purposes; medicinal alcoholic beverages for the treatment of metabolic diseases, diabetes, hypertension, hypercholesterolemia, and hyperlipidemia; anticoagulants; blood plasma; biological preparations for medical purposes for the treatment of metabolic diseases, diabetes, hypertension, hypercholesterolemia, and hyperlipidemia; antitoxic sera; antitoxins; mixed biological preparations for medical purposes for the treatment of metabolic diseases, diabetes, hypertension, hypercholesterolemia, and hyperlipidemia; vaccines; amino acids for medical purposes; biological tissue cultures for medical purposes; greases for medical purposes; febrifuges; anti-inflammatories; amino acids for veterinary purposes; enzyme preparations for veterinary purposes; diagnostic preparations for veterinary purposes; biological preparations for veterinary purposes for the treatment of metabolic diseases; biological tissue cultures for veterinary purposes; medicines for veterinary purposes for the treatment of metabolic diseases; greases for veterinary purposes; lotions for veterinary purposes; asthmatic tea; opotherapy preparations; organotherapy preparations; haematogen being a dietary supplement; medical preparations for slimming purposes; dietary supplement preparations of trace elements for human and animal use; pharmaceutical drugs for medical purposes for the treatment of metabolic diseases, diabetes, hypertension, hypercholesterolemia, and hyperlipidemia; medicines for human purposes for the treatment of metabolic diseases, diabetes, hypertension, hypercholesterolemia, and hyperlipidemia; dietary supplements for animals; ferments for pharmaceutical purposes; enzymes for medical purposes; starch for dietetic or pharmaceutical purposes; appetite suppressant pills; slimming pills; tanning pillsACTIVE
031Animal foodstuffs; fish meal being animal feed; synthetic animal feed; rice bran being animal feed; mixed animal feed; soy sauce cakes being animal feed; soy bean meal being animal feed; starch pulp being animal feed; meat scrap meal being animal food; formula animal feed; pet food; oil cake being animal feed; dog biscuits; groats for poultry; livestock fattening preparations, namely, mash for fattening livestock; salt licks for cattle; cattle cake; cattle food; maize cake for cattle; rape cake for cattle; draff for animal consumption; flaxseed for animal consumption; algarovilla for animal consumption; marc being unprocessed fruit residue; fish meal for animal consumption; yeast for animal consumption; grains for animal consumption; wheat germ for animal consumption; roots for animal consumption; distillery waste for animal consumption; lime for animal forage; by-products of the processing of cereals, for animal consumption; flaxseed meal for animal consumption; rice meal for animal forage; bran mash for animal consumption; straw for animal forage; stall food for animals; animal fattening preparations, namely, mash for fattening livestock; edible chews for animals; peanut cake for animals; peanut meal for animals; cuttle bone being food for birds; bird food; rice bran for animal consumption; flax meal for use as animal fodder; marc, namely, unprocessed fruit residue; beverages for pets; hay; mash for fattening livestockACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2026RFNTREFUSAL PROCESSED BY IB
Dec 21, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 21, 2025RFRRREFUSAL PROCESSED BY MPU
Nov 16, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 8, 2025DOCKASSIGNED TO EXAMINER
Nov 7, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Nov 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 16, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance